[1]刘 晶,朱 瑜,胡 蝶,等.新型1927nm铥激光联合妥塞敏治疗黄褐斑疗效观察[J].中国美容医学,2022,(3):33-36.
 LIU Jing,ZHU Yu,HU Die,et al.The Clinical Efficacy and Safety of a Novel 1 927 nm Thulium Laser Combined with Transamin in the Treatment of Melasma[J].Medical Aesthetics and Beauty,2022,(3):33-36.
点击复制

新型1927nm铥激光联合妥塞敏治疗黄褐斑疗效观察()
分享到:

《中国美容医学》[ISSN:1008-6445/CN:61-1347/R]

卷:
期数:
2022年3期
页码:
33-36
栏目:
出版日期:
2022-03-10

文章信息/Info

Title:
The Clinical Efficacy and Safety of a Novel 1 927 nm Thulium Laser Combined with Transamin in the Treatment of Melasma
文章编号:
1008-6455(2022)03-0033-04
作者:
刘 晶1朱 瑜1胡 蝶1胡光蕾1何淑娟1焦立鑫2苟朋昊3曾维惠1
(1.西安交通大学第二附属医院皮肤病院 陕西 西安 710004 ;2.汉中华美奥莱医学整形美容医院皮肤科 陕西 汉中 723000 ;3.旬邑县医院皮肤科 陕西 咸阳 711300 )
Author(s):
LIU Jing1 ZHU Yu1 HU Die1 HU Guanglei1 HE Shujuan1 JIAO Lixin2 GOU Penghao3 ZENG Weihui1
(1.Department of Dermatology, the Second Affiliated Hospital of Xian Jiaotong University, Xian 710004, Shaanxi, China;2.Department of Dermatology, Hanzhong Huamei Aolai Medical Plastic Surgery Hospital, Hanzhong 723000, Shaanxi, China;3.Department of Dermatology,Xunyi County Hospital, Xianyang 711300, Shaanxi, China)
关键词:
黄褐斑1927nm铥激光妥塞敏非剥脱点阵激光联合治疗
Keywords:
melasma1 927 nm thulium fiber laser transamin non-ablative fractional laser combination therapy
分类号:
R758.41
文献标志码:
A
摘要:
目的:评估小能量、低密度新型1927nm铥激光联合妥塞敏治疗黄褐斑的临床疗效及安全性。方法:选取30例黄褐斑患者(Fitzpatrick皮肤Ⅲ~Ⅳ型),随机分为1927nm+妥塞敏组和妥塞敏组。1927nm+妥塞敏组采用新型1927nm铥激光联合妥塞敏治疗,1927nm铥激光治疗重复次数1或2次,治疗间隔4~8周,接受3~5次治疗;妥塞敏口服250毫克/次,早晚各一次,口服3个月;妥塞敏组口服妥塞敏,用法同1927nm+妥塞敏组。由两位研究者评估治疗前、治疗后1个月、3个月和6个月改良的黄褐斑面积及严重程度指数(mMASI)评分、医生整体评价法(Physician global assessment, PGA)、患者自评以及不良反应。结果:与治疗前相比,两组治疗后1个月、3个月及6个月mMASI评分下降,差异有统计学意义(P=0.000);1927 nm+妥塞敏组治疗后1个月、3个月的mMASI评分下降大于妥塞敏组,差异均有统计学意义(P=0.001,P=0.005);同时,1927nm+妥塞敏组治疗后1个月、3个月的PGA评分优于妥塞敏组,差异有统计学意义(χ2=5.932,P=0.035;χ2=7.897,P=0.016);1927nm+妥塞敏组治疗后无明显红斑、水肿、色素沉着以及疼痛等不良反应。结论:新型1927nm铥激光联合妥塞敏治疗黄褐斑安全有效,值得临床推广应用。
Abstract:
Objective To evaluate the clinical efficacy and safety of a novel 1 927 nm thulium laser combined with Transamin in the treatment of Melasma. Methods A total of 30 subjects(Fitzpatrick Ⅲ skin - Ⅳ type) were randomly divided into 1?927?nm+Transamin group and Transamin group.The experimental group was treated with a novel 1?927?nm thulium laser combined with Transamin. The number of 1 927 thulium laser repeats was 1 or 2.Treatment interval was 3 to 5 sessions, and 4 to 8 weeks.Transamin was taken orally 250 mg/time, once in the morning and once in the evening, for 3 months.The control group was given Transamin orally, the same as the experimental group.Modified melasma area and severity index (mMASI) score, Physician Global Assessment(PGA), patient self-assessment, and adverse events were assessed by two investigators before treatment,1, 3,and 6 months after treatment. Results Compared with previous treatment, the mMASI scores in both groups improved to varying degrees 1, 3 and 6 months after treatment, with statistical significance(P=0.000).In the experimental group, mMASI scores descends greater than the control group to varying degrees 1 and 6 months after treatment ,with statistical significance (P=0.001,P=0.001).Meawhile, the PGA scores in 1 and 3 months after treatment were better than the control group, with statistical significance (χ2=5.932,P=0.035,χ2=7.897,P=0.016).There were no adverse reactions of erythema, edema, chromatism and pain in the treatment group. Conclusion The new 1 927 nm thulium laser combined with Transamin is safe and effective in the treatment of melasma,which is worthy of clinical application.

相似文献/References:

[1]李丽娜,郑颖娜,邓丽娜,等. Q开关1 064nm激光联合果酸治疗黄褐斑的临床研究[J].中国美容医学,2018,(03):63.
 LI Li-na,ZHENG Ying-na,DENG Li-na,et al. Q - switched 1 064nm Laser Combined with Acid in the Treatment of Chloasma[J].Medical Aesthetics and Beauty,2018,(3):63.
[2]孙 慧,吴志波,倪小丽,等. 微针导入氨甲环酸联合Q开关1 064nm激光治疗黄褐斑疗效观察[J].中国美容医学,2018,(05):26.
 SUN Hui,WU Zhi-bo,NI Xiao-li,et al. Clinical Observation of Microneedle Importing Tranexamic Acid into Skin Combinedwith Q Switch 1 064nm Laser for Treating Chloasma[J].Medical Aesthetics and Beauty,2018,(3):26.
[3]黄朝卫,解翠林,石 年,等. 女性黄褐斑的临床特点及点阵激光治疗的效果分析[J].中国美容医学,2018,(06):85.
 HUANG Chao-wei,XIE Cui-lin,SHI Nian,et al.The Clinical Characteristics of Female Chloasma and Cosmetic Effect of Dot Matrix Laser Treatment[J].Medical Aesthetics and Beauty,2018,(3):85.
[4]李 卉,胡霜红,王 娟,等. 药物水光注射治疗黄褐斑对患者CK10、SOD及MDA表达水平的影响[J].中国美容医学,2018,(07):75.
 LI Hui,HU Shuang-hong,WANG Juan,et al. Effect on the Expression of CK10, SOD and MDA in Patients with Drug Water Injection in the Treatment of Chloasma[J].Medical Aesthetics and Beauty,2018,(3):75.
[5]杨国峰,张 力.桃红四物合六味地黄汤加减治疗黄褐斑临床疗效评价[J].中国美容医学,2018,(08):133.
 YANG Guo-feng,ZHANG Li. Evaluation of Clinical Efficacy of Modified Taohong Siwu Decoction Combined with six Ingredients Dihuang Decoction in the Treatment of Chloasma[J].Medical Aesthetics and Beauty,2018,(3):133.
[6]陈小燕,刘晓梅,马 瑛,等.优化强脉冲光技术治疗黄褐斑疗效分析[J].中国美容医学,2018,(09):34.
 CHEN Xiao-yan,LIU Xiao-mei,MA Ying,et al.The Efficacy of Optimizedintense Pulsed Light in the Treatment of Chloasma[J].Medical Aesthetics and Beauty,2018,(3):34.
[7]韦强梅,江 贺,李冬花,等. 755nm皮秒激光联合口服氨甲环酸治疗黄褐斑疗效观察[J].中国美容医学,2018,(10):34.
 WEI Qiang-mei,JIANG He,LI Dong-hua,et al. Effectiveness of Combination Picosecond 755nm Laser with Tranexamic Acid in the Treament of Melasma[J].Medical Aesthetics and Beauty,2018,(3):34.
[8]黄朝卫,解翠林,石 年,等.光子嫩肤与调Q激光治疗黄褐斑疗效对比[J].中国美容医学,2018,(10):45.
 HUANG Chao-wei,XIE Cui-lin,SHI Nian,et al. The Contrast Effect of Photorejuvenation and Q Laser Used in Chloasma[J].Medical Aesthetics and Beauty,2018,(3):45.
[9]贾华魁,李琳婕.非剥脱性Lux 1 540nm点阵激光联合氢醌乳膏治疗黄褐斑临床疗效研究[J].中国美容医学,2019,(01):67.
 JIA Hua-kui,LI Lin-jie. Clinical Study on Non-stripping Lux 1 540nm Lattice Laser Combined withHydroquinone Cream in the Treatment of Chloasma[J].Medical Aesthetics and Beauty,2019,(3):67.
[10]张玉洁,刘 瑜,陈阳美,等. 微针导入类人胶原蛋白联合Q开关1 064nm激光治疗黄褐斑疗效观察[J].中国美容医学,2019,(05):8.
 ZHANG Yu-jie,LIU Yu,CHEN Yang-mei,et al. Observation on Clinical Efficacy of Microneedle Importing Human-like Collagen intoSkin Combined with Q-switch 1 064nm Nd:YAG Laser in the Treatment of Melasma[J].Medical Aesthetics and Beauty,2019,(3):8.

更新日期/Last Update: 2022-04-06